knowledge -WSS

knowledge

author：explore 2025-09-27 16:47:35 - browse：78

Alex Hogan/STAT

SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years.

But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week. More likely, it’s the surge of deals that came in December. Whatever the reason, sentiment around Union Square in recent days was markedly more positive this year.

Most everyone I spoke to this week noticed the change in tenor. “I’m feeling a lot of good energy, honestly,” Mira Chaurushiya, senior partner at VC Westlake Village BioPartners, told me Tuesday. “It’s not only what happened the last few weeks of the year, but what people are projecting moving forward.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Use wet bulb globe temperature, not heat index, to protect workers

explore

WSS

Why psychiatrists like me stop taking insurance

Telehealth startups turn to complex chronic diseases

After gene therapy, two congenitally deaf children hear for the first time

U.K. sequencing study surfaces new findings about tumor DNA

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Use wet bulb globe temperature, not heat index, to protect workers

Wikipedia

knowledge

explore

Hepatitis C has a cure — but many Americans still lack access to it

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

The high cost of giving birth even with insurance

CDC wastewater surveillance dashboard to track bird flu hotspots

BioMarin wins approval for gene therapy to treat hemophilia A

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

The high cost of giving birth even with insurance

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

How to save PrEP access — and even expand it

Morgan Health, with ambitious aims, wants you to know it’s still here

leisure time

AdventHealth escalates lawsuit against insurance vendor Multiplan

AdventHealth escalates lawsuit against insurance vendor Multiplan

Apple Watch's A

Bird flu outbreak in cows is latest avian flu curveball

Feng Zhang CRISPR delivery startup lays off quarter of staff

H5N1 communication has been strictly for the birds

Wikipedia

explore

hotspot

focus